Tumour necrosis factor-α (TNF-α) and miRNA expression in frontal and temporal neocortex in Alzheimer's disease and the effect of TNF-α on miRNA expression in Vitro

International Journal of Molecular Epidemiology and Genetics

Volumn 2, Issue 2, 2011, Pages 156-162

  Culpan, Doris ^a   Kehoe, Patrick G ^a   Love, Seth ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Alzheimer's disease; MicroRNA; SH SY5Y cells; Tumour necrosis factor

Indexed keywords

MICRORNA; MICRORNA 128A; MICRORNA 128B; MICRORNA 155; MICRORNA 27A; MICRORNA 27B; MICRORNA LET7A; MICRORNA LET7B; RETINOIC ACID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN TISSUE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FRONTAL CORTEX; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MALE; NEOCORTEX; NEUROBLASTOMA CELL; TEMPORAL CORTEX;

EID: 79958109878     PISSN: None     EISSN: 19481756     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Ambros V. The functions of animal microRNAs. Nature 2004; 431: 350-355.
2. Bartel DP and Chen C-Z. Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat Rev Genet 2004; 5: 396-400.
3. Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W and Tuschl T. Identification of Tissue-Specific MicroRNAs from Mouse. Current biology: CB 2002; 12: 735-739.
4. Sempere L, Freemantle S, Pitha-Rowe I, Moss E, Dmitrovsky E and Ambros V. Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biology 2004; 5: R13.
5. NELSON PT, HATZIGEORGIOU AG and MOURELATOS Z. miRNP:mRNA association in polyribosomes in a human neuronal cell line. RNA 2004; 10: 387-394.
6. Berezikov E, Thuemmler F, van Laake LW, Kondova I, Bontrop R, Cuppen E and Plasterk RHA. Diversity of microRNAs in human and chimpanzee brain. Nat Genet 2006; 38: 1375-1377.
7. Beuvink I, Kolb FA, Budach W, Garnier A, Lange J, Natt F, Dengler U, Hall J, Filipowicz W and Weiler J. A novel microarray approach reveals new tissue-specific signatures of known and predicted mammalian microRNAs. Nucleic Acids Research 2007; 35: e52.
8. Nelson PT and Keller JN. RNA in Brain Disease: No Longer Just "The Messenger in the Middle".Journal of Neuropathology & Experimental Neurology 2007; 66: 461-468, 410.1097/1001.jnen.0000240474.0000227791.f0000240473.
9. Nelson PT, Wang WX and Rajeev BW. MicroRNAs (miRNAs) in Neurodegenerative Diseases. Brain Pathology 2008; 18: 130-138.
10. Barbato C, Arisi, I, Frizzo, M E, Brandi, R, Da Sacco, L, Masotti, A. Computational Challenges in miRNA Target Predictions: To Be or Not to Be a True Target? J Biomed Biotechnol 2009; 2009: 803069:
11. Kocerha J, Faghihi MA, Lopez-Toledano MA, Huang J, Ramsey AJ, Caron MG, Sales N, Willoughby D, Elmen J, Hansen HF, Orum H, Kauppinen S, Kenny PJ and Wahlestedt C. MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunction. Proceedings of the National Academy of Sciences 2009; 106: 3507-3512.
12. Cogswell John P WJ, Taylor Ian A, Waters Michelle, Shi Yunling, Cannon Brian, Kelnar Kevin, Kemppainen Jon, Brown David, Chen Caifu, Prinjha Rab K, Richardson Jill C., Saunders Ann M., Roses Allen D., Richards Cynthia A. Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways. JOURNAL OF ALZHEIMER'S DISEASE 2008; 14: 27-41.
13. Hebert SS and De Strooper B. MOLECULAR BIOLOGY: miRNAs in Neurodegeneration. Science 2007; 317: 1179-1180.
14. Wang W-X, Rajeev BW, Stromberg AJ, Ren N, Tang G, Huang Q, Rigoutsos I and Nelson PT. The Expression of MicroRNA miR-107 Decreases Early in Alzheimer's Disease and May Accelerate Disease Progression through Regulation of {beta}-Site Amyloid Precursor Protein- Cleaving Enzyme 1. J. Neurosci. 2008; 28: 1213-1223.
15. Boissonneault V, Plante I, Rivest S and Provost P. MicroRNA-298 and MicroRNA-328 Regulate Expression of Mouse ß-Amyloid Precursor Protein- converting Enzyme 1. Journal of Biological Chemistry 2009; 284: 1971-1981.
16. Heneka MT and O'Banion MK. Inflammatory processes in Alzheimer's disease. Journal of Neuroimmunology 2007; 184: 69-91.
17. Boche D and Nicoll JA. SYMPOSIUM: Clearance of Aß from the Brain in Alzheimer' Disease: The Role of the Immune System in Clearance of Aß from the Brain. Brain Pathology 2008; 18: 267-278.
18. Sastre M, Walter J and Gentleman S. Interactions between APP secretases and inflammatory mediators. Journal of Neuroinflammation 2008; 5: 25.
19. McGeer P and McGeer E. Local neuroinflammation and the progression of Alzheimer's disease. J Neurovirol 2002; 8: 529-538.
20. Paganelli R, Di Iorio A, Patricelli L, Ripani F, Sparvieri E, Faricelli R, Iarlori C, Porreca E, Di Gioacchino M and Abate G. Proinflammatory cytokines in sera of elderly patients with dementia: levels in vascular injury are higher than those of mild-moderate Alzheimer's disease patients. Experimental Gerontology 2002; 37: 257-263.
21. Holmes C, Cunningham C, Zotova E, Woolford J, Dean C, Kerr S, Culliford D and Perry VH. Systemic inflammation and disease progression in Alzheimer disease. Neurology 2009; 73: 768-774.
22. Janelsins M, Mastrangelo M, Oddo S, LaFerla F, Federoff H and Bowers W. Early correlation of microglial activation with enhanced tumor necrosis factor-alpha and monocyte chemoattractant protein-1 expression specifically within the entorhinal cortex of triple transgenic Alzheimer's disease mice. J Neuroinflammation 2005; 2: 23.
23. Billings L, Oddo S, Green K, McGaugh J and Laferla F. Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron 2005; 45: 675-688.
24. Junker A, Krumbholz M, Eisele S, Mohan H, Augstein F, Bittner R, Lassmann H, Wekerle H, Hohlfeld R and Meinl E. MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47. Brain 2009; 132: 3342-3352.
25. FARAONI, #160, Isabella, ANTONETTI R, Francesca, CARDONE, John, BONMASSAR and Enzo. MiR-155 gene: A typical multifunctional microRNA. Amsterdam, PAYS-BAS: Elsevier, 2009.
26. Buck AH, Perot J, Chisholm MA, Kumar DS, Tuddenham L, Cognat V, Marcinowski L, Dölken L and Pfeffer S. Post-transcriptional regulation of miR-27 in murine cytomegalovirus infection. RNA 2010; 16: 307-315.
27. Johnson CD, Esquela-Kerscher A, Stefani G, Byrom M, Kelnar K, Ovcharenko D, Wilson M, Wang X, Shelton J, Shingara J, Chin L, Brown D and Slack FJ. The let-7 MicroRNA Represses Cell Proliferation Pathways in Human Cells. Cancer Research 2007; 67: 7713-7722.
28. Schultz J, Lorenz, Peter, Gross, Gerd, Ibrahim, Saleh and Kunz, Manfred. MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage- independent growth. Cell Research 2008; 18: 549-557.
29. Chhabra R, Adlakha YK, Hariharan M, Scaria V and Saini N. Upregulation of miR-23a-27a-24-2 Cluster Induces Caspase-Dependent and-Independent Apoptosis in Human Embryonic Kidney Cells. PLoS ONE 2009; 4: e5848.
30. Morris JC, Edland S, Clark C, Galasko D, Koss E, Mohs R, van Belle G, Fillenbaum G and Heyman A. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease. Neurology 1993; 43: 2457.
31. Kenchappa P, Yadav A, Singh G, Nandana S and Banerjee K. Rescue of TNFa-inhibited neuronal cells by IGF-1 involves Akt and c-Jun Nterminal kinases. Journal of Neuroscience Research 2004; 76: 466-474.
32. Livak KJ and Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (Duluth) 2001; 25: 402-408.
33. Beutler B and Cerami A. The Biology of Cachectin/ TNF -- A Primary Mediator of the Host Response. Annual Review of Immunology 1989; 7: 625-655.
34. Deleault KM, Skinner SJ and Brooks SA. Tristetraprolin regulates TNF TNF-[alpha] mRNA stability via a proteasome dependent mechanism involving the combined action of the ERK and p38 pathways. Molecular Immunology 2008; 45: 13-24.
35. Lanzrein A, Johnston C, Perry V, Jobst K, King E and Smith A. Longitudinal study of inflammatory factors in serum, cerebrospinal fluid, and brain tissue in Alzheimer disease: interleukin-1beta, interleukin-6, interleukin-1 receptor antagonist, tumor necrosis factor-alpha, the soluble tumor necrosis factor receptors I and II, and alpha1-antichymotrypsin. Alzheimer Dis Assoc Disord 1998; 12: 215-227.
36. Lukiw WJ. Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus. NeuroReport 2007; 18: 297-300 210.1097/ WNR.1090b1013e3280148e3280148b.
37. Schonrock N, Ke YD, Humphreys D, Staufenbiel M, Ittner LM, Preiss T and Götz J. Neuronal MicroRNA Deregulation in Response to Alzheimer's Disease Amyloid-β. PLoS ONE 2010; 5: e11070.
38. Smirnova L, Gräfe A, Seiler A, Schumacher S, Nitsch R and Wulczyn FG. Regulation of miRNA expression during neural cell specification. European Journal of Neuroscience 2005; 21: 1469-1477.
39. Carrettiero DC, Hernandez I, Neveu P, Papagiannakopoulos T and Kosik KS. The Cochaperone BAG2 Sweeps Paired Helical Filament- Insoluble Tau from the Microtubule. J. Neurosci. 2009; 29: 2151-2161.
40. Kolachala VL, Wang L, Obertone TS, Prasad M, Yan Y, Dalmasso G, Gewirtz AT, Merlin D and Sitaraman SV. Adenosine 2B Receptor Expression Is Post-transcriptionally Regulated by MicroRNA. Journal of Biological Chemistry 2010; 285: 18184-18190.
41. Cullen BR. Transcription and Processing of Human microRNA Precursors. Molecular Cell 2004; 16: 861-865.
42. Evangelisti C, Florian MC, Massimi I, Dominici C, Giannini G, Galardi S, Buè MC, Massalini S, McDowell HP, Messi E, Gulino A, Farace MG and Ciafrè SA. MiR-128 up-regulation inhibits Reelin and DCX expression and reduces neuroblastoma cell motility and invasiveness. The FASEB Journal 2009; 23: 4276-4287.
43. Fukuda Y, Kawasaki H and Taira K. Exploration of human miRNA target genes in neuronal differentiation. Nucleic Acids Symposium Series 2005; 49: 341-342.
44. Tili E, Michaille J-J, Cimino A, Costinean S, Dumitru CD, Adair B, Fabbri M, Alder H, Liu CG, Calin GA and Croce CM. Modulation of miR-155 and miR-125b Levels following Lipopolysaccharide/ TNF-a Stimulation and Their Possible Roles in Regulating the Response to Endotoxin Shock. The Journal of Immunology 2007; 179: 5082-5089.
45. O'Connell RM, Rao DS, Chaudhuri AA, Boldin MP, Taganov KD, Nicoll J, Paquette RL and Baltimore D. Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder. The Journal of Experimental Medicine 2008; 205: 585-594.
46. Kehoe PG, Miners S and Love S. Angiotensins in Alzheimer's disease friend or foe? Trends in neurosciences 2009; 32: 619-628.
47. Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Williams A, Jones N, Thomas C, Stretton A, Morgan AR, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Morgan K, Brown KS, Passmore PA, Craig D, McGuinness B, Todd S, Holmes C, Mann D, Smith AD, Love S, Kehoe PG, Hardy J, Mead S, Fox N, Rossor M, Collinge J, Maier W, Jessen F, Schurmann B, van den Bussche H, Heuser I, Kornhuber J, Wiltfang J, Dichgans M, Frolich L, Hampel H, Hull M, Rujescu D, Goate AM, Kauwe JSK, Cruchaga C, Nowotny P, Morris JC, Mayo K, Sleegers K, Bettens K, Engelborghs S, De Deyn PP, Van Broeckhoven C, Livingston G, Bass NJ, Gurling H, McQuillin A, Gwilliam R, Deloukas P, Al- Chalabi A, Shaw CE, Tsolaki M, Singleton AB, Guerreiro R, Muhleisen TW, Nothen MM, Moebus S, Jockel K-H, Klopp N, Wichmann HE, Carrasquillo MM, Pankratz VS, Younkin SG, Holmans PA, O'Donovan M, Owen MJ and Williams J. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet 2009; 41: 1088-1093.
48. Vasudevan S, Tong Y and Steitz JA. Switching from Repression to Activation: MicroRNAs Can Up-Regulate Translation. Science 2007; 318: 1931-1934.